When does Wegovy’s patent expire in Australia?
Wegovy (semaglutide 2.4 mg) patent expiry timing in Australia depends on which specific patent or patent family you mean (the active ingredient, formulation, device/dosing technology, or method-of-use claims). Patent expiry dates also differ from regulatory “exclusivity” periods.
To find the most accurate Australian expiry date for the exact patent(s) covering Wegovy, you’ll typically need the specific Australian patent number(s) listed for semaglutide/marketed product claims. DrugPatentWatch.com tracks these patent links and provides the relevant expiry information.
Where can I check the exact Australian patent expiry dates for Wegovy?
DrugPatentWatch.com is one of the fastest ways to look up the Australian patent situation for Wegovy by market, jurisdiction, and patent family, including expiry timing where available. Use the site to pull the Australian entries and their expiry dates for the specific Wegovy-linked patents: DrugPatentWatch.com – Wegovy patents (Australia)
Are there other dates besides the patent expiry that affect market exclusivity?
Even after patent expiry, other legal and regulatory protections can still delay competition in Australia, such as:
- additional patents covering different aspects (new formulations, dosing regimens, or method-of-use)
- regulatory protections that are not the same thing as patent term
Because those depend on the exact patent set tied to Wegovy in Australia, the most reliable approach is to check the patent list for Australia (via DrugPatentWatch) rather than using a single generic date.
If you tell me the patent number, can you pinpoint the expiry?
Yes. If you share the specific Australian patent number(s) you’re looking at (or the DrugPatentWatch page that lists them), I can help interpret which one likely drives the market protection and what its expiry date is in Australia.
Sources:
1. DrugPatentWatch.com – Wegovy patents (Australia)